Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.54 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 3/20 | 0.51 |
| ▸ | PPARA | Q07869 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | AGXT | P21549 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17078190 | 0.91 | PPARG (0.42) | CYP1A2CYP2A6UGT2B7PPARGPPARA | |
| SCHEMBL8615951 | 0.91 | AKR1C3 (0.44) | CYP1A2UGT2B7PPARGPPARAMAPT | |
| SCHEMBL30933409 | 0.91 | AKR1C3 (0.44) | CYP1A2UGT2B7PPARGPPARAMAPT | |
| SCHEMBL28772163 | 0.89 | UGT2B7 (0.47) | CYP1A2CYP2A6UGT2B7PPARGPPARA | |
| SCHEMBL20911140 | 0.84 | CYP1A2 (0.50) | CYP1A2CYP2A6UGT2B7PPARGPPARA | |
| SCHEMBL21131538 | 0.84 | CYP1A2 (0.50) | CYP1A2CYP2A6UGT2B7PPARGPPARA | |
| SCHEMBL276584 | 0.83 | CYP1A2 (0.58) | CYP1A2CYP2A6UGT2B7PPARGPPARA | |
| SCHEMBL14184695 | 0.81 | UGT2B7 (0.43) | CYP1A2CYP2A6UGT2B7PPARGPPARA | |
| SCHEMBL7857138 | 0.79 | CYP1A2 (0.54) | CYP1A2CYP2A6UGT2B7PPARGPPARA | |
| SCHEMBL2256256 | 0.79 | CYP2A6 (0.54) | CYP1A2CYP2A6UGT2B7PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111217946-B | Composition comprising a compound containing a vinyl group | 东京应化工业株式会社 | 2022-12-06 | — | — | CN | claimed |
| CN-101240073-B | Soot dispersants and lubricating oil compositions containing same | INFINEUM INT LTD | 2013-11-27 | — | — | CN | claimed |
| CN-117003621-B | 2, 7-Di (phenylethynyl) fluorenyl diol derivative crystal and preparation method thereof | 江苏永星化工股份有限公司 | 2025-07-25 | — | — | CN | disclosed |
| US-12281198-B2 | Thermoplastic resin and optical member | TEIJIN LIMITED (JP) | 2025-04-22 | — | — | US | disclosed |
| US-12240944-B2 | Optical lens | TEIJIN LIMITED (JP) | 2025-03-04 | — | — | US | disclosed |
| EP-3932972-B1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER | TEIJIN LTD (JP) | 2025-02-19 | — | — | EP | disclosed |
| CN-113474685-B | optical lens | 帝人株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113795476-B | Compound having fluorene skeleton and method for producing same | 帝人株式会社 | 2024-04-09 | — | — | CN | disclosed |
| CN-111465589-B | Compound having fluorene skeleton and method for producing same | 帝人株式会社 | 2024-01-05 | — | — | CN | disclosed |
| CN-117003621-A | 2, 7-di (phenylethynyl) fluorenyl diol derivative crystal and preparation method thereof | 江苏永星化工股份有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-117003621-A | 2, 7-di (phenylethynyl) fluorenyl diol derivative crystal and preparation method thereof | 江苏永星化工股份有限公司 | 2023-11-07 | — | — | CN | disclosed |
| WO-2019163829-A1 | ANTI-REFLECTION FILM AND LAYERED PRODUCT FILM HAVING ANTI-REFLECTION FILM | 三菱瓦斯化学株式会社 | 2019-08-29 | — | — | WO | disclosed |
| US-9703193-B2 | Onium salt, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-07-11 | — | — | US | disclosed |
| US-9645491-B2 | Sulfonium salt, chemically amplified resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-05-09 | — | — | US | disclosed |
| US-20160349612-A1 | SULFONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-12-01 | — | — | US | disclosed |
| US-20160320698-A1 | ONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-11-03 | — | — | US | disclosed |
| CN-103274937-B | Soot dispersion agent and the lubricating oil composition containing this dispersion agent | ENFENORM INTERNATIONAL CO. (GB) | 2016-02-03 | — | — | CN | disclosed |
| CN-101240073-B | Soot dispersants and lubricating oil compositions containing same | INFINEUM INT LTD | 2013-11-27 | — | — | CN | disclosed |
| CN-103274937-A | Soot dispersants and lubricating oil compositions containing same | INFINEUM INT LTD | 2013-09-04 | — | — | CN | disclosed |
| US-4024159-A | Process for the production of liquid acetals | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160349612-A1 | SULFONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS | FANCF, PPM1F, SOS2 | CYP1A2 4271/4885CYP2A6 3207/4885UGT2B7 2882/4885 |
| US-20160320698-A1 | ONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | SLC6A5, EIF2B5, EIF2B4 | CYP1A2 3313/4885CYP2A6 3679/4885UGT2B7 2015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.